WHO says new drugs urgently needed to fight 12 'priority pathogens' | Reuters
Drug-resistant infections: what we're doing now to tackle this slow-moving pandemic | News | Wellcome
US Government Drive CARB-X Announces Funding for Global Scientists Racing to Discover New Antibiotics to Treat Superbugs - Bugworks, Only Company From Asia in This List of Winners
Drug-Resistant Bugs Are A Growing Concern In COVID-era, Say Global Health Leaders - Health Policy Watch
International priorities for antimicrobial resistance a need for
Fixing the antibiotic innovation pipeline - EPHA
Tackling Antimicrobial Resistance: Meeting the Global Challenge of AMR | Centre for Medical Ethics and Law
The Global Response to AMR: Momentum, success and critical gaps - Access to Medicine Foundation
Stewardship and Access - Carb-X
Wellcome Trust launches global project to map antibiotic resistance - The Pharmaceutical Journal
SDRI conference on Twitter: "#SDRI2017 speaker highlight Tim Jinks @ wellcometrust @CARB_X #antibioticdiscovery models & $ https://t.co/rlZEbd1Xss https://t.co/ZKzBQhTMQq" / Twitter
Timothy Jinks on coordinating AMR containment research and policy-making efforts
International priorities for antimicrobial resistance a need for
Antibiotic resistance likely to kill 2.4 million across Europe, Australia and North America by 2050
Timothy Jinks (@TimothyJinks1) / Twitter
The drugs don't work: what happens after antibiotics? | Antibiotics | The Guardian
PDF) A time for action: antimicrobial resistance needs global response
Tim Jinks's research works | Wellcome, London and other places